4//SEC Filing
Millar Kerri-Ann 4
Accession 0000950170-25-044348
CIK 0001645460other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 4:00 PM ET
Size
5.3 KB
Accession
0000950170-25-044348
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-03-21+200,000→ 200,000 totalExercise: $0.99Exp: 2035-03-20→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on September 21, 2025.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739126
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 4:00 PM ET
- Size
- 5.3 KB